Collegium Pharmaceutical Founder Michael Ph's 2018 pay jumps 63% to $4.6M
Collegium Pharmaceutical reports 2018 executive compensation
By ExecPay News
Published: March 15, 2019
Collegium Pharmaceutical reported fiscal year 2018 executive compensation information on March 15, 2019.
In 2018, six executives at Collegium Pharmaceutical received on average a compensation package of $2.6M, a 27% increase compared to previous year.
Average pay of disclosed executives at Collegium Pharmaceutical
Michael Heffernan, R. Ph, Founder, received $4.6M in total, which increased by 63% compared to 2017. 48% of Ph's compensation, or $2.2M, was in option awards. Ph also received $222K in non-equity incentive plan, $317K in salary, $1.8M in stock awards, as well as $60K in other compensation.
Joseph J. Ciaffoni, Chief Executive Officer, received a compensation package of $3.5M, which increased by 41% compared to previous year. 39% of the compensation package, or $1.4M, was in option awards.
Scott Dreyer, Executive Vice President and Chief Commercial Officer, earned $2M in 2018.
Paul Brannelly, Chief Financial Officer, received $2M in 2018, which increases by 80% compared to 2017.
Alison Fleming, Chief Technology Officer, earned $1.9M in 2018, a 89% increase compared to previous year.
Shirley Kuhlmann, General Counsel, received $1.6M in 2018.
Related executives
Michael Ph
Collegium Pharmaceutical
Founder
Paul Brannelly
Collegium Pharmaceutical
Chief Financial Officer
Joseph Ciaffoni
Collegium Pharmaceutical
Chief Executive Officer
Scott Dreyer
Collegium Pharmaceutical
Executive Vice President and Chief Commercial Officer
Alison Fleming
Collegium Pharmaceutical
Chief Technology Officer
Shirley Kuhlmann
Collegium Pharmaceutical
General Counsel
You may also like
Source: SEC filing on March 15, 2019.